MAP2K1 and melanoma: MAP2K1 mutations do not have a well-described association with T-cell neoplasms but MAP2K1 C121S is known to be an activating mutation25 and has been observed in cases of melanoma, gastrointestinal adenocarcinomas, histiocytic neoplasms, and others24,26.